L’utilisation de la Metformine

Type :

Résumé

L’utilisation de la metformine est associée à une réduction de la mortalité dans une population diversifiée souffrant de COVID-19 et de diabète, article paru dans Frontiers in Endocrinology

Extrait

“Background: Coronavirus disease-2019 (COVID-19) is a growing pandemic with an increasing death toll that has been linked to various comorbidities as well as racial disparity. However, the specific characteristics of these at-risk populations are still not known and approaches to lower mortality are lacking.

Methods: We conducted a retrospective electronic health record data analysis of 25,326 subjects tested for COVID-19 between 2/25/20 and 6/22/20 at the University of Alabama at Birmingham Hospital, a tertiary health care center in the racially diverse Southern U.S. The primary outcome was mortality in COVID-19-positive subjects and the association with subject characteristics and comorbidities was analyzed using simple and multiple linear logistic regression. […] ”

Références & liens

https://www.frontiersin.org/articles/10.3389/fendo.2020.600439/full

Aller au contenu principal